Koss Olinger Consulting, LLC Astrazeneca PLC Transaction History

Koss Olinger Consulting, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$59.26 - $71.14 $285,514 - $342,752	-4,818 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$55.72 - $67.12 $146,822 - $176,861	-2,635 Reduced 35.35%	4,818 $320,000
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $80,813 - $95,489	-1,496 Reduced 16.72%	7,453 $434,000
Q3 2021 Nov 09, 2021	SELL	$55.56 - $60.79 $193,293 - $211,488	-3,479 Reduced 27.99%	8,949 $537,000
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $51,470 - $63,971	1,063 Added 9.35%	12,428 $744,000

Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $535,973 - $618,710	11,365 New	11,365 $565,000

1,246

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

Stay updated on Koss Olinger Consulting, LLC with notifications on news.